An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: In vitro and in vivo studies

Cancer Journal

Volumn 6, Issue 4, 2000, Pages 243-248

  He, H ^a   Hirokawa, Y ^a   Levitzki, A ^a   Maruta, H ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

PAK; PP1; Ras; Src family kinases; Tumor suppressors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN ERBB2; PROTEIN KINASE P60; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GENE ACTIVATION; GENE MUTATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SARCOMA;

3T3 CELLS; ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TRANSFORMED; ENZYME ACTIVATION; FEMALE; MICE; MICE, NUDE; ONCOGENE PROTEIN P21(RAS); PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PYRAZOLES; PYRIMIDINES; SARCOMA; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 0033794165     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. G proteins, PIP2, and actin-cytoskeleton in the control of cancer growth
2. A brain Sr/Thr kinase activated by CDC42 and Rac
3. 2+-ATPase activity of Aeanthamoeba myosin I
4. Cloning and characterization of a Dictyostelium myosin I heavy chain kinase activated by CDC42 and Rac
5. Functions of unconventional myosins
6. The adaptor protein NCK links receptor Tyr kinases with the Ser/Thr kinase PAK
7. PAK kinase are directly coupled to the PIX family of nucleotide exchange factors
8. Activation of LIM-kinase by PAK couples Rac/CDC42 GTPase signaling to actin cytoskeletal dynamics
9. Alered regulation of TGF-beta-1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-RAS
10. A heparin-binding growth factor secreted by macrophage-like cells is related to EGF
11. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells
12. Enhanced expression of heregulin in ErbB2 and c-Ha-RAS transformed mouse and human mammary epithelial cells
13. EGF dependent activation of the Src family kinases
14. C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells
15. A Tyr-phosphorylated protein that binds to an important regulatory region on the Cool family of PAK-binding proteins
16. Discovery of a novel, potent, and Src family-selective Tyr kinase inhibitor
17. Crystal structure of HCK in complex with a Src family-selective Tyr kinase inhibitor
18. Role of PIP2 in Ras/Rac induced disruption of the cortactin-actomyosin II complex and malignant transformation
19. Tyrosine kinase inhibition: An approach to drug development
20. Signals from the RAS, Rac, and Rho GtTPases converge on the PAK kinase in Rat-1 fibroblasts
21. Treatment of RAS-induced cancers by the F-actin bundling drug MKT-077
22. Treatment of RAS-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445
23. The Src family Tyr kinase are required for PDGF-mediated signaling transduction in NIH 3T3 cells
24. Requirement for c-Ras during viral oncogene (v-Src) transformation
25. An EGF receptor/Ral GTPase signaling cascade regulates c-Src activity and substrate specificity
26. The anti-RAS cancer drug MKT-077 is an F-actin cross-linker
27. Non-RAS targets for farnesyltransferase inhibitors: Focus on Rho